Related Experiment Video
Updated: Jul 17, 2026
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Decadal trends (2011-2020) in financial allocation and utilization, and their relationship with outcome indicators
Ajith Ramalingam1, Ranjit Mankeshwar1, Geeta Pardeshi1
1Department of Community Medicine, Grant Government Medical College and Sir JJ Group of Hospitals, Mumbai, Maharashtra, India.
Background:
Tuberculosis (TB) continues to be a major public health challenge in India. The National Health Mission (NHM) provides financial support for the National Tuberculosis Programme (NTP). This study examines trends in financial allocation and utilization under the NTP and their relationship with key TB outcome indicators in Maharashtra.
Methods:
Secondary data from the NHM's Programme Implementation Plans (PIPs), Records of Proceedings (ROPs), and annual TB reports for Maharashtra from 2011 to 2020 were analyzed. Trends in financial allocation and utilization were examined in terms of total funds and percentage changes across various categories. The median and interquartile range (IQR) were calculated for fund utilization proportions. Correlations between fund utilization and TB outcome indicators were assessed using Spearman correlation coefficients and scatter plots. Data analysis and visualization were conducted using R software (version 4.4.3).
Results:
A consistent increase in both fund allocation and utilization was observed throughout the decade, with notable peaks in 2019 and 2020. The highest median fund utilization rates were recorded for Supervision & Monitoring (85.53 %, IQR: 49.06 %-90.88 %) and Public-Private Mix (85.25 %, IQR: 72.49 %-90.93 %). Fund utilization was positively correlated with TB case notification rates (ρ = 0.663, p = 0.037) and treatment success rates (ρ = 0.906, p = 0.001), and negatively correlated with TB case fatality rates (ρ = -0.855, p = 0.002).
Conclusion:
Enhanced financial support and strategic management of funds are essential for achieving TB elimination targets. Continuous investment and optimization of funding strategies are required to sustain and improve TB program outcomes.
Related Concept Videos
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
01:23Tuberculosis
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...